PVDA Biosciences
Enterprise number 1025196364 · Active (000 Normale toestand)
PVDA Biosciences is a besloten vennootschap registered in Lokeren, Belgium, incorporated on 7 Jul 2025. Its registered activity is speur- en ontwikkelingswerk op biotechnologisch gebied.
Company details
- Enterprise number
- 1025196364 · official register
- Status
- 000 Normale toestand
- Legal form
- Besloten Vennootschap
- Incorporated
- 7 Jul 2025 (1 years)
- Registered address
- 9160 Lokeren
- Province
- East Flanders
- Activity
- 72101 Speur- en ontwikkelingswerk op biotechnologisch gebied
- Industry
- Scientific research and development
- Accounts overdue
- No
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in East Flanders
- 360SURVEY Aalst
- 4U2 PATENT SERVICE Oudenaarde
- ABLYNX Gent
- ADRIAENS CONSULTING Aalter
- AEPHIS CONSULTING Gent
- AETHER RENEWABLE CHEMICALS Gent
- AJ Daly Consulting Gent
- AMBERCO Gent
- APOTHEKER-BIOLOOG DIMITRI BAETENS Lokeren
- AREADNE Temse
- ART-COMPANY Evergem
- ASTERION RESEARCH & DEVELOPMENT Gent
Questions about PVDA Biosciences
What is the enterprise number of PVDA Biosciences?
PVDA Biosciences is registered under enterprise number 1025196364 in the official register of Belgium. View it at the official register.
Is PVDA Biosciences still active?
Yes. PVDA Biosciences is registered as active (status: 000 Normale toestand).
Has PVDA Biosciences gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for PVDA Biosciences in the official data.
When was PVDA Biosciences founded?
PVDA Biosciences was incorporated on 7 Jul 2025.
Where is PVDA Biosciences registered?
PVDA Biosciences's registered address is in 9160 Lokeren (East Flanders), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.